Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$415M |
| 2 |
Eli Lilly
LLY
|
+$402M |
| 3 |
Goldman Sachs
GS
|
+$384M |
| 4 |
McDonald's
MCD
|
+$379M |
| 5 |
Tesla
TSLA
|
+$304M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.98B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$596M |
| 3 |
AT&T
T
|
+$460M |
| 4 |
Synchrony
SYF
|
+$398M |
| 5 |
Honeywell
HON
|
+$342M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.97% |
| 2 | Financials | 4.82% |
| 3 | Healthcare | 4.18% |
| 4 | Industrials | 3.64% |
| 5 | Consumer Discretionary | 3.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FRC
5601
DELISTED
First Republic Bank
FRC
| $897K | ﹤0.01% |
8,923
-43,814
| -83% | -$4.31M |
|
|
CRC
5602
DELISTED
California Resources Corporation
CRC
| $897K | ﹤0.01% |
34,884
-52,264
| -60% | -$1.13M |
|
|
BDSI
5603
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $897K | ﹤0.01% |
169,260
+148,437
| +713% | +$678K |
|
5604
CALL
IMAX
IMAX
$2.9B
| $896K | ﹤0.01% |
39,500
-25,900
| -40% | -$553K |
|
5605
PUT
Skywest
SKYW
$4.18B
| $896K | ﹤0.01% |
16,500
+5,000
| +43% | +$257K |
|
5606
State Street SPDR Portfolio Mortgage Backed Bond ETF
SPMB
$7.05B
| $896K | ﹤0.01% |
+34,704
| New | +$887K |
|
|
VISN
5607
PUT
Vistance Networks Inc
VISN
$2.66B
| $895K | ﹤0.01% |
41,200
+19,000
| +86% | +$399K |
|
5608
CALL
ProShares Short Russell2000
RWM
$98.9M
| $895K | ﹤0.01% |
22,000
-15,500
| -41% | -$646K |
|
|
MAGN
5609
Magnera Corp
MAGN
$444M
| $895K | ﹤0.01% |
4,875
-4,128
| -46% | -$695K |
|
5610
PUT
ING
ING
$102B
| $894K | ﹤0.01% |
73,600
+16,600
| +29% | +$201K |
|
|
CSLT
5611
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
| $894K | ﹤0.01% |
238,543
+174,077
| +270% | +$553K |
|
5612
CALL
Vanguard Total Bond Market
BND
$161B
| $893K | ﹤0.01% |
11,000
-4,400
| -29% | -$351K |
|
5613
Invesco Pharmaceuticals ETF
PJP
$500M
| $893K | ﹤0.01% |
13,702
-1,064
| -7% | -$69.9K |
|
5614
JPMorgan International Bond Opportunities ETF
JPIB
$2.13B
| $892K | ﹤0.01% |
18,181
-18,559
| -51% | -$901K |
|
5615
PUT
Kinross Gold
KGC
$32.4B
| $891K | ﹤0.01% |
259,000
-940,100
| -78% | -$3.14M |
|
5616
PUT
A.O. Smith
AOS
$8.45B
| $890K | ﹤0.01% |
16,700
-5,000
| -23% | -$249K |
|
5617
CALL
Allot
ALLT
$383M
| $889K | ﹤0.01% |
112,000
+98,500
| +730% | +$708K |
|
5618
PUT
ANI Pharmaceuticals
ANIP
$1.76B
| $889K | ﹤0.01% |
+12,600
| New | +$741K |
|
|
CVGW
5619
CALL
DELISTED
Calavo Growers
CVGW
| $889K | ﹤0.01% |
10,600
-16,600
| -61% | -$1.35M |
|
5620
WisdomTree Trust WisdomTree Interest Rate Hedged High Yield Bond Fund
HYZD
$260M
| $889K | ﹤0.01% |
38,240
-61,928
| -62% | -$1.44M |
|
5621
TransDigm Group
TDG
$69.5B
| $888K | ﹤0.01% |
1,957
-7,147
| -79% | -$2.9M |
|
|
RUTH
5622
PUT
DELISTED
Ruth's Hospitality Group, Inc.
RUTH
| $888K | ﹤0.01% |
+34,700
| New | +$848K |
|
5623
Aurinia Pharmaceuticals
AUPH
$2.06B
| $887K | ﹤0.01% |
136,521
+20,363
| +18% | +$135K |
|
5624
Innospec
IOSP
$2.31B
| $887K | ﹤0.01% |
10,641
-5,021
| -32% | -$374K |
|
5625
CALL
MarketAxess Holdings
MKTX
$5.72B
| $886K | ﹤0.01% |
3,600
+1,700
| +89% | +$385K |
|
Similar funds
Ken Griffin's Q1 2019 Portfolio in Review
As of Q1 2019, Ken Griffin held 10,449 positions worth $201B, up 10% from $183B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Ken Griffin withdrew a net $13B in Q1 2019, closing 1,251 positions and reducing 3,810 holdings. Its most notable exit was Twenty-First Century Fox, Inc. Class A, an estimated $223M position sold in full.
By sector, the portfolio is most concentrated in Technology at 6% of assets, up from 4.8% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Ken Griffin opened a new position in Elanco Animal Health worth $251M.
- Ken Griffin's largest Q1 2019 buy was Elanco Animal Health: 7,832,197 shares worth $251M.
- Ken Griffin added most to Walt Disney in Q1 2019, an estimated $415M increase.
- Ken Griffin's biggest Q1 2019 reduction was Amazon, cutting an estimated $1.98B.
- Ken Griffin fully exited Twenty-First Century Fox, Inc. Class A in Q1 2019, selling an estimated $223M.
- Ken Griffin's ten largest holdings make up 24% of its $201B portfolio in Q1 2019.
- Ken Griffin opened 1,429 new positions and closed 1,251 in Q1 2019.
- Ken Griffin's portfolio value rose 10% quarter-over-quarter to $201B.
Based on Citadel Advisors's 13F filing for Q1 2019, filed 15 May 2019.